DRUG compared with BIOA: revenue, margins and what each company keeps, and the suppliers and customers both name

DRUGBright Minds Biosciences Inc.

Mkt capRevenueRevenue

BIOABioAge Labs, Inc.

Mkt capRevenueRevenue

Compare

DRUGBright Minds Biosciences Inc.

BIOABioAge Labs, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DRUG

No earnings history for DRUG.

BIOA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±20.3%▼−3.61%×0.18

Q2 FY26±59.0%▲+2.64%×0.04

May 8 '26±10.8%▲+0.95%×0.08

Q1 FY26±16.5%▼−13.53%×0.82

= impliedDRUG realized, solidBIOA realized, hatchedOne scale, both sides: full bar = 59%× = |realized| ÷ impliedSource: market data

DRUGBright Minds Biosciences Inc.

22.87▲+10.48%· post 22.66

Mkt cap$175.6MRevenue—Revenue—

BIOABioAge Labs, Inc.

5.30▼−4.38%· post 5.30

ClosedNov 6 '26

Mkt cap$245.2MRevenue$298,000Q3 FY26Revenue$9MFY25

Compare

ClosedNov 6 '26

DRUGBright Minds Biosciences Inc.

BIOABioAge Labs, Inc.

22.87▲+10.48%post 22.66

Price

5.30▼−4.38%post 5.30

$175.6M

Mkt cap

$245.2M

—

Revenue

$298,000Q3 FY26

—

Revenue

$9MFY25

DRUG22.87▲+10.48%vsBIOA5.30▼−4.38%ClosedNov 6 '26